Kelker Pharma’s Nutrilinq Genesis tackles “Ozempic face” and other GLP-1 treatment side effects

Kelker Pharma has announced its upcoming launch of Nutrilinq Genesis, touted as the “first science-backed” nutritional support system for GLP-1 receptor agonist drug users. It was developed to help the majority of people experiencing adverse effects from rapid weight loss to improve their experience while using GLP-1 medications.

With the growing demand for GLP-1 drugs for weight loss, a high percentage of medication users are experiencing temporary and long-term side effects, including critical nutritional gaps, highlights the brand.